| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Zevra Therapeutics, Inc.'s insiders have reduced their positions by a net 74,966 shares worth roughly $838K. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 417.2K | $4.28M | -20,000 | |
| CFO | 143.5K | $1.47M | - | |
| Dir | 123.4K | $1.27M | - | |
| Other | 62.3K | $639.0K | - | |
| Other | 37.6K | $385.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2016 | Christal M M Mickle | VP Prod Dev | Buy | 5,000 | $4.95 | $24,750.00 | +243.9% | |
| Aug 17, 2016 | Travis C Mickle | President & CEO | Buy | 5,000 | $4.95 | $24,750.00 | +243.9% | |
| Mar 29, 2016 | Christal M M Mickle | VP Prod Dev | Buy | 2,450 | $14.57 | $35,703.30 | -612.5% | |
| Mar 29, 2016 | Travis C Mickle | President & CEO | Buy | 2,450 | $14.57 | $35,703.30 | +7.9% | |
| Apr 21, 2015 | Gordon K Johnson | COO & CFO | Buy | 2,000 | $11.00 | $22,000.00 | New | |
| Apr 21, 2015 | David S Tierney53 | Director | Buy | 5,000 | $11.00 | $55,000.00 | New |